Enhancement of Sindbis virus self-replicating RNA vaccine potency by linkage of herpes simplex virus type 1 VP22 protein to antigen

Journal of Virology

Volumn 75, Issue 5, 2001, Pages 2368-2376

  Cheng, W F ^a   Hung, C F ^a   Chai, C Y ^a   Hsu, K F ^a   He, L ^a   Ling, M ^a   Wu, T C ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; PROTEIN VP22; RNA VACCINE; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA; VIRUS VACCINE; VIRUS VECTOR;

ANIMAL CELL; ANTIGEN BINDING; ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; DRUG POTENCY; FEMALE; HERPES SIMPLEX VIRUS 1; INTRACELLULAR TRANSPORT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN TRANSPORT; REPLICON; RNA REPLICATION; SINDBIS VIRUS; T LYMPHOCYTE; VACCINATION; WART VIRUS;

ANIMALS; ANTIGEN PRESENTATION; APOPTOSIS; CANCER VACCINES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; FEMALE; GENETIC VECTORS; HISTOCOMPATIBILITY ANTIGENS CLASS I; INTERFERON TYPE II; LUNG NEOPLASMS; MICE; MICE, INBRED C57BL; ONCOGENE PROTEINS, VIRAL; RNA REPLICASE; RNA, VIRAL; SINDBIS VIRUS; VACCINATION; VACCINES, SYNTHETIC; VIRAL STRUCTURAL PROTEINS;

EID: 0035127885     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.5.2368-2376.2001     Document Type: Article

References (33)

1. Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes
2. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
3. Outcome of immunization of cynomolgus monkeys with recombinant Semliki Forest virus encoding human immunodeficiency virus type 1 envelope protein and challenge with a high dose of SHIV-4 virus
4. Enhancing immune responses using suicidal DNA vaccines
5. Sindbis virus expression vectors: Packaging of RNA replicons by using defective helper RNAs
6. Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene
7. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: Similarity of L3T4 to the human Leu-3/T4 molecule
8. Intercellular delivery of thymidine kinase prodrug activating enzyme by the herpes simplex virus protein, VP22
9. Marek's disease virus (MDV) homologues of herpes simplex virus type 1 UL49 (VP22) and UL48 (VP16) genes: High-level expression and characterization of MDV-1 VP22 and VP16
10. Intercellular trafficking and protein delivery by a herpesvirus structural protein
11. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells
12. Translation of Sindbis virus mRNA: Analysis of sequences downstream of the initiating AUG codon that enhance translation
13. DNA immunization against herpes simplex virus: Enhanced efficacy using a Sindbis virus-based vector
14. Distinctions between bovine herpesvirus 1 and herpes simplex virus type 1 VP22 tegument protein subcellular associations
15. Cell proliferation, apoptosis, oncogene, and tumor suppressor gene status in adenosis with comparison to benign prostatic hyperplasia, prostatic intraepithelial neoplasia, and cancer
16. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens
17. The NK-1.1(-) mouse: A model to study differentiation of murine NK cells
18. Enhancement of tumor-specific immune response with plasmid DNA replicon vectors
19. DNA and RNA-based vaccines: Principles, progress and prospects
20. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen
21. Apoptosis in bladder cancer as related to standard prognostic factors and prognosis
22. CD40-independent pathways of T cell help for priming of CD8(+) cytotoxic T lymphocytes
23. DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1
24. In vitro-synthesized infectious RNA as an attenuated live vaccine in a flavivirus model
25. Exposing the immunology of naked DNA vaccines
26. Intercellular delivery of functional p53 by the herpesvirus protein VP22
27. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: Expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo
28. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement
29. A "public" T-helper epitope of the E7 transforming protein of human papillomavirus 16 provides cognate help for several E7 B-cell epitopes from cervical cancer-associated human papillomavirus genotypes
30. Intramuscular administration of E7-transfected dendritic cells generates the most potent E7-specific anti-tumor immunity
31. Engineering an intracellular pathway for MHC class II presentation of HPV-16 E7
32. A reassessment of the role of B7-1 expression in tumor rejection
33. Cancer therapy using a self-replicating RNA vaccine